Institutional

July 27, 2017

São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.

Click on Download to access the full text of the decision.

See file

Back

Last related news

May 17, 2024

Kasznar Leonardos was recognized as the most admired office in Rio de Janeiro by the Análise Advocacia Regional 2024

We, at Kasznar Leonardos, are honored to announce that we have been selected as one of the Most Admired law firms by … Kasznar Leonardos was recognized as the most admired office in Rio de Janeiro by the Análise Advocacia Regional 2024

Kasznar Leonardos

May 16, 2024

Kasznar Leonardos attends the INTA’s Annual Meeting 2024

It’s coming! Kasznar Leonardos will be at International Trademark Association (INTA)‘s Annual Meeting in Atlanta, Georgia, this week, between May 18th and … Kasznar Leonardos attends the INTA’s Annual Meeting 2024

April 30, 2024

Kasznar Leonardos’ legal assistant won ASIPI contest in partnership with UNH Franklin Pierce

Our legal assistant Antonio Freitas Jr. was one of the winners of the ASIPI scholarship competition in partnership with UNH Franklin Pierce School of Law. Antonio will … Kasznar Leonardos’ legal assistant won ASIPI contest in partnership with UNH Franklin Pierce

Kasznar Leonardos